Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$1.02 - $2.57 $508,211 - $1.28 Million
-498,247 Reduced 62.74%
295,840 $316,000
Q3 2023

Nov 14, 2023

BUY
$2.52 - $5.69 $156,088 - $352,438
61,940 Added 8.46%
794,087 $2.03 Million
Q2 2023

Aug 14, 2023

BUY
$5.0 - $7.66 $2.25 Million - $3.45 Million
450,752 Added 160.18%
732,147 $3.97 Million
Q4 2022

Feb 14, 2023

BUY
$2.11 - $4.3 $373,240 - $760,631
176,891 Added 169.27%
281,395 $1.21 Million
Q3 2022

Nov 14, 2022

BUY
$2.13 - $4.0 $222,593 - $418,016
104,504 New
104,504 $237,000

Others Institutions Holding ASRT

About Assertio Holdings, Inc.


  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $40.5M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track This Portfolio

Track Kennedy Capital Management, Inc. Portfolio

Follow Kennedy Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.